These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22386702)

  • 1. Telmisartan reduces triglyceride levels over other angiotensin II receptor blockers: a meta-analysis of randomized head-to-head trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Jun; 157(3):403-7. PubMed ID: 22386702
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of telmisartan for blood pressure reduction among angiotensin II receptor blockers: a meta-analysis of head-to-head randomized trials.
    Takagi H; Mizuno Y; Goto SN; Umemoto T;
    Int J Cardiol; 2013 Sep; 167(6):3051-6. PubMed ID: 23219133
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of telmisartan on C-reactive protein levels: a meta-analysis of randomized controlled trials.
    Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T
    Int J Cardiol; 2012 Apr; 156(2):238-41. PubMed ID: 22353440
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
    Takagi H; Mizuno Y; Yamamoto H; Goto SN; Umemoto T;
    Hypertens Res; 2013 Apr; 36(4):368-73. PubMed ID: 23235712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-independent effects of telmisartan on regression of left ventricular mass: a meta-analysis and meta-regression of randomized controlled trials.
    Takagi H; Mizuno Y; Iwata K; Goto SN; Umemoto T
    Int J Cardiol; 2013 May; 165(3):564-7. PubMed ID: 23041001
    [No Abstract]   [Full Text] [Related]  

  • 6. Telmisartan increases adiponectin levels: a meta-analysis and meta-regression of randomized head-to-head trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Mar; 155(3):448-51. PubMed ID: 22192290
    [No Abstract]   [Full Text] [Related]  

  • 7. Telmisartan improves insulin sensitivity: a meta-analysis of randomized head-to-head trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Apr; 156(1):92-6. PubMed ID: 22192303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Telmisartan].
    Krankenpfl J; 2005; 43(4-6):110-1. PubMed ID: 16171056
    [No Abstract]   [Full Text] [Related]  

  • 9. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
    Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
    J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.
    Volpe M
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):1061-72. PubMed ID: 23030295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [INNOVATION study].
    Ogawa D; Makino H
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():451-4. PubMed ID: 21667499
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
    Xi GL; Cheng JW; Lu GC
    Am J Hypertens; 2008 May; 21(5):546-52. PubMed ID: 18437146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lowering blood pressure with sartans. Are there differences?].
    MMW Fortschr Med; 2002 Nov; 144(47):63. PubMed ID: 12532530
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Barnett AH
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus.
    Kulkarni RB; Kulkarni BN; Hariharan RS; Naikwadi A; Gawde A; Baliga V; Desai A
    J Indian Med Assoc; 2005 Mar; 103(3):187-91. PubMed ID: 16173297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In the DETAIL. Kidney protection in manifestations of microalbuminuria].
    MMW Fortschr Med; 2006 Jun; 148(26):51. PubMed ID: 16875382
    [No Abstract]   [Full Text] [Related]  

  • 18. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
    MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381
    [No Abstract]   [Full Text] [Related]  

  • 19. The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?
    Tylicki L; Lizakowski S; Rutkowski P; Renke M; Sulikowska B; Heleniak Z; Donderski R; Bednarski R; Przybylska M; Manitius J; Rutkowski B
    Kidney Blood Press Res; 2012; 36(1):335-43. PubMed ID: 23235363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan.
    Francischetti EA; Celoria BM; Francischetti A; Genelhu VA
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):289-303. PubMed ID: 18327991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.